Introduction
============

Nowadays, bacterial infections especially those caused by multi-drug resistant (MDR) bacteria have become one of the great challenges for modern healthcare. Therefore, discovering new antibacterial compounds with improved activity is necessary. Majority of scientists define multi-drug resistance (MDR) as ˝resistance to at least 3 classes of antimicrobial agents˝ (Falagas et al., 2006\[[@R16]\]). Since the ancient time, the idea of finding healing powers in plants has been noteworthy. Plants produce a vast array of secondary metabolites that in many cases, these substances act as defense mechanisms against predation by herbivores, microorganisms and insects; also similar substances can be produced by plants as a part of their normal growth and development or in response to stress (Mirjana et al., 2004\[[@R22]\]; Cowan, 1999\[[@R12]\]). *Peganum harmala* L. (Zygophyllaceae), that is also called Harmal, Suryin Rue, is a perennial, bushy, and wild-growing flowering plant with short creeping root which may grow to 30-100 cm high (Shamsa et al., 2007\[[@R30]\]; Goel et al., 2009\[[@R19]\]; Mahmoodian et al., 2002\[[@R20]\]) is known as "Espand\'\' in Iran and Harmal in North Africa and African Rue, Mexican Rue, Syrian Rue or Turkish Rue in United States (Mahmoodian et al., 2002\[[@R20]\]). It\'s native to semi-arid rangeland, steppe area and sandy soils (Mahmoodian et al., 2002\[[@R20]\]). This plant is widely distributed in North Africa, Mediterranean, the Middle East, Pakistan, India and Iran and has been introduced in America and Australia (Asghari and Lockwood, 2002\[[@R6]\]; Ehsanpour and Saadat, 2002\[[@R15]\]; Yousefi et al., 2009\[[@R35]\]). *P. harmala* traditionally has been used in Iran as an antiseptic and disinfectant agent by burning its seeds (Fathiazada et al., 2006\[[@R17]\]; Arshad et al., 2008\[[@R5]\]). This plant has been considered for the treatment of a variety of human ailments, such as lumbago, asthma, colic, jaundice and as a stimulant emmenagogue (Bukhari et al., 2008\[[@R8]\]). The most pharmacological active compounds of *P. harmala* are several alkaloids which are found in the seeds and roots (Mirzaie et al., 2007\[[@R23]\]). There are various reports that *P. harmala* had different pharmacological activities including spontaneous effect (Fathiazada et al., 2006\[[@R17]\]), anti-tumor effect (Goel et al., 2009\[[@R19]\]), insecticidal effect (Goel et al., 2009\[[@R19]\]), caving malaria (Goel et al., 2009\[[@R19]\]), anti-leishmanial (Mirzaie et al., 2007\[[@R23]\]), anti-spasmodic (Asghari and Lockwood, 2002\[[@R6]\]), anti-histaminic (Asghari and Lockwood, 2002\[[@R6]\]), vasorelaxant effect (Asghari and Lockwood, 2002\[[@R6]\]), wound healing (Derakhshanfar et al., 2009\[[@R14]\]), anti-oxidant activity (Astulla et al., 2008\[[@R7]\]), leukemic healing (Zaker et al., 2007\[[@R36]\]), hypoglycemic effect (Singh et al., 2008\[[@R32]\]), immuno-modulator properties (Astulla et al. 2008\[[@R7]\]), analgesic and anti-inflammatory properties (Muhi-eldeen et al., 2008\[[@R25]\]). Also, it has been reported that this plant had antibacterial, antifungal and antiviral effects (Shonoudam et al., 2008\[[@R31]\]); this study focused on the seed extract of *P. harmala*. However, a study with focusing on antibacterial activity of different parts of *P. harmala* has not yet been documented. The objective of the present study was to assess the antibacterial property of the methanol extract from different parts of *P. harmala* including flower, seed, leave, stem and root against some most important human pathogenic bacteria.

Materials and Methods
=====================

Plant material collection and identification
--------------------------------------------

Different parts of *P. harmala* were collected from hills around Behbahan (south east of Khuzestan province, Iran) in 2009. Sample collection was done in April for leave and stem, in May for flower, in June for seed and in September for root. The plant used in this study was taxonomically identified by the Herbarium of Agricultural Science Faculty, Shahid Chamran University, Ahvaz, Iran. Voucher specimens were deposited at the Department of Biology, Shahid Chamran University, Iran.

Preparation of extract
----------------------

The leaf, flower, seed and stem were shade dried at room temperature for ten days while the root was shade dried for twenty days. These mentioned parts were ground to a fine powder. The powder (1 g) was extracted using 10 ml of methanol-distilled water solution (8:2 v/v), centrifuged at 3000 rpm for 15 min and collecting the supernatant. This process was repeated for three times. Then, solvent removed by evaporation (Darabpour et al., 2010\[[@R13]\]).

Tested microorganisms
---------------------

A total of thirteen bacteria were selected for this study. Gram positive bacterial species were *Bacillus anthracis*, *Bacillus cereus*, *Bacillus pumilus*, *Staphylococcus aureus*, *Staphylococcus epidermidis*,*Listeria monocytogenes* *and Streptococcus pyogenes*. Gram negative bacterial species were *Pseudomonas aeruginosa, Brucella melitensis*, *Proteus mirabilis*, *Salmonella typhi*, *Escherichia coli and Klebsiella pneumoniae*. These species were originally isolated from clinical specimens and identified by standard biochemical reactions based on morphological and biochemical characters according to the methods described in Bergey\'s manual for systematic bacteriology (Garrity et al., 2006\[[@R18]\]). Different characteristics were Gram stain, pigmentation, motility and utilization of different carbon and nitrogen sources and so on.

Inoculums preparation for antibacterial assay
---------------------------------------------

All of the tested bacteria were cultured over night at 37 °C in the Muller-Hinton Broth (MHB, Merck) and used as inoculums. The turbidimetry of the suspension was adjusted to the McFarland 0.5 turbidity standard (10^8^ cfu/ml) (Owen and Palombo, 2007\[[@R27]\]; Chomnawang et al., 2005\[[@R10]\]).

Antibacterial assay procedure
-----------------------------

At first, a total of 0.1 ml of bacterial suspension was poured on each plate containing Muller-Hinton Agar (MHA, Merck). The lawn culture was prepared by sterile cotton swab and allowed to remain in contact for 1 min. Four concentrations of methanolic extracts (50, 100, 200, and 400 mg/ml) from each of the used parts of *P. harmala* were prepared. The sterile filter paper discs (6 mm diameter) (Cermelli et al., 2008\[[@R9]\]) were saturated by 35 μl of different concentrations of each extract and then were placed on lawn cultures. The Petri dishes were subsequently incubated at 37 °C for 24 h and the inhibition zone around each disc was measured in mm. This experiment was carried out in duplicate. As positive controls, discs containing novobiocin 30 μg, nalidixic acid 30 μg, carbenicillin 100 μg, colistin 10 μg, streptomycin 10 μg and methicillin 5 μg were used. All of these synthetic antibiotic discs were prepared from Difco. Discs impregnated with 80 % and methanol was also included to test if they had an inhibitory effect on the test bacteria.

MIC and MBC determination
-------------------------

The MIC (Minimal Inhibitory Concentration) and MBC (Minimal Bactericidal Concentration) of methanolic extracts from the most effective parts of *P. harmala* were determined against somewhat important and more sensitive bacteria. MIC was determined by the macro broth dilution assay method (NCCLS, 2008\[[@R26]\]; Motamedi et al., 2010\[[@R24]\]). In the tube dilution assay, standard bacterial suspension and different concentrations of extract (0.312, 0.625, 1.25, 2.5, 5, 10, 20, 40, 80, 160, and 200 mg/ml) were added to tubes containing 1 ml Muller-Hinton Broth (MHB, Merck). These tubes were incubated at 37 °C for 24 h. The first tube in the above series without sign of visible growth was considered as the MIC. MBC was determined by culturing one standard loop of the tubes with no apparent growth on MHA and subsequent incubation at 37 °C for 24 h. The least concentration that inhibited colony formation on agar was considered as MBC for the extract.

Study of the synergistic effect
-------------------------------

To determine the synergistic effect of the most effective parts of *P. harmala* with synthetic antibiotics, 400 mg/ml concentration of their extract was added to the discs containing these antibiotics (novobiocin, colistin and carbenicillin) and their effect was evaluated by disc diffusion method on the most important bacterial pathogens among tested bacteria (Motamedi et al., 2010\[[@R24]\]).

Physicochemical treatment of the active extracts
------------------------------------------------

To find out thermostability of antibacterial compound, 1 ml aliquots of the most effective parts extract at 100 mg/ml concentration were added to the sterile screw capped ampoules and treated by temperature at 4 °C in refrigerator for 24 h and 25, 37, 56, 70 and 90 °C in a water bath for 30 min (Salama and Marraiki, 2009\[[@R29]\]; Amin et al., 2010\[[@R4]\]). To determine the effect of pH, the methanolic extract of the most effective parts at 100 mg/ml concentration were treated at pH ranges from 2 to 10 using either 1N HCl or 1N NaOH solutions for 30 min at 4 °C (Salama and Marraiki, 2009\[[@R29]\]). Finally, the result of these treatments was found by measurement of the inhibition zone against one of the most important human pathogenic bacterium.

Fractionation of the most effective extract by Thin Layer Chromatography (TLC)
------------------------------------------------------------------------------

The methanolic extracts of the most effective parts of *P. harmala* were analyzed by TLC; the presence of different constituent types in screened extracts was established by adding 15 µl of extracts at 100 mg/ml concentration on silica gel plate (Merck 60 F254 10-20 cm), the plate was developed in a chamber saturated with solvent system n-butanol: acetic acid: distilled water (v/v 4:4:1) as mobile phases. The separated components were visualized under visible and ultraviolet light (254 and 366 nm). Also, the retardation factor (*R~f~*) values of the spots were determined.

Results
=======

On the basis of the obtained results that are shown in Figures 1-5[(Fig. 1)](#F1){ref-type="fig"}[(Fig. 2)](#F2){ref-type="fig"}[(Fig. 3)](#F3){ref-type="fig"}[(Fig. 4)](#F4){ref-type="fig"}[(Fig. 5)](#F5){ref-type="fig"}, the seed and root extracts of *P. harmala* have a broad antibacterial activity so that all of the tested clinical bacteria were sensitive to these two extracts while flower, leaf and stem were presented a relatively poor antibacterial activity. Increasing the antibacterial activity of the different parts of *P. harmala* was observed at higher concentrations. Among Gram positive bacteria, *S. epidermidis* and *Str. pyogenes* were the most sensitive strains to the seed and root extracts while among Gram negative bacteria, *K. pneumoniae* and *Br. melitensis* had the most sensitivity to the seed extract and *K. pneumoniae* and *E. coli* to the root extract too. *P. mirabilis* and *P. aeruginosa* were the most resistant strains to these two extracts. Antibacterial activity of the root extract against tested Bacillus species and *S. aureus* was better than the seed extract. Moreover, the seed extract of *P. harmala* was more effective than the root extract against Gram negative bacteria. The flower, leaf and stem extracts of *P. harmala* showed inhibitory effect against *S. epidermidis*, *Str. pyogenes* and *B. anthracis* at the highest concentration. Among the used parts of *P. harmala*, the flower extract showed the least antibacterial activity. All of the tested clinical bacteria were MDR strains. *E. coli*, *P. aeruginosa*, *S. typhi* and *L. monocytogenes* were the most resistant strains to the synthetic antibiotics (Figure 6[(Fig. 6)](#F6){ref-type="fig"}). Tested *S. aureus* exhibited resistance to methicillin. Also, all of the tested bacteria were resistant to colistin. Considering antibacterial activity of the different parts of *P. harmala*, seed and root extracts were chosen for further study.

Results of MIC and MBC determination (Table 1[(Tab. 1)](#T1){ref-type="fig"}) showed that MIC and MBC values for the seed and root extract of *P. harmala* against MRSA are equal (0.625 mg/ ml). Also, these values for seed extract against *E. coli* and *S. typhi* were the same (0.625 mg/ml) while for the root extract were different. Moreover, MIC values for seed and root extracts against *B. anthracis* were 2.5 and 1.25 mg/ml, respectively while MBC values were 5 and 2.5 mg/ml, respectively.

Based on the results from pH treatment (Figure 7[(Fig. 7)](#F7){ref-type="fig"}), the best activity of the seed extract was observed at the pH ranges from 4 to 7 while for root extract was in pH 6 and 7. The observed zone of inhibition after treatment of the seed extract with the different temperature was equal to untreated extract (20 mm) (Figure 8[(Fig. 8)](#F8){ref-type="fig"}) but, antibacterial activity of the root extract partially was affected when treated at 70 and 90 °C. In general, antibacterial activity of these two extracts was not considerably affected after temperature and pH treatment.

As we can see in Figures 9A and B[(Fig. 9)](#F9){ref-type="fig"} and Table 2[(Tab. 2)](#T2){ref-type="fig"}, there are spots (at 254 and 336 nm) with different *Rf* values or molecular weight in seed and root extracts of *P. harmala*. Some spots are more intensive in one extract comparing with other extract. In general, the obtained results from TLC revealed that these two parts of *P. harmala* have several different constituents.

The results of the combination of seed and root extracts of *P. harmala* with novobiocin, colistin and carbenicillin showed that these combinations have synergistic effect against tested bacteria (Table 3[(Tab. 3)](#T3){ref-type="fig"}). Combination of seed and root extract with novobiocin against *E. coli*, *B. anthracis*, *K. pneumoniae* and MRSA showed a remarkable synergistic effect. Although *E. coli* and *L. monocytogenes* were resistant to colistin, the combination of this synthetic antibiotic with seed and root extract showed excellent antibacterial activity against these two bacteria. Synergistic effect of seed extract in combination with novobiocin against *E. coli*, *S. typhi* and *K. pneumoniae* was better than root extract while about of *B. anthracis* and *S. aureus*, efficiency of the root extract was better than seed extract. Furthermore, the observed synergism of root extract with colistin against *E. coli* and *L. monocytogenes* was better than the seed extract. Combination of the root extract of *P. harmala* with carbenicillin presented a better antibacterial activity against *B. anthracis* and MRSA compared with seed extract. Meanwhile, the seed and root extract in combination with carbenicillin showed a relatively weak synergistic activity against MRSA.

Discussion
==========

In recent years, an explosive spread of MDR bacterial pathogens has become a serious concern worldwide in terms of public health and economic effects. Medicinal plants have been shown to be a potential source of pharmaceutical natural products. The comparison between pharmaceutical effect of different parts of a medicinal plant can give a good vision for accomplishing further study with more efficiency. In this study, for the first time we have attempted to compare antibacterial activity of the different parts of *P. harmala*. Each of the used parts of *P. harmala* was collected at the best month of collection in terms of their secondary metabolite content. Among the evaluated different parts of *P. harmala*, the seed and root extract showed the best antibacterial activity against tested clinical bacterial pathogens (Figures 1-5[(Fig. 1)](#F1){ref-type="fig"}[(Fig. 2)](#F2){ref-type="fig"}[(Fig. 3)](#F3){ref-type="fig"}[(Fig. 4)](#F4){ref-type="fig"}[(Fig. 5)](#F5){ref-type="fig"}). The seed and root are known as reservoir parts in plants, so, it is very likely that these parts served as arsenal of the secondary metabolites with antibacterial activity in *P. harmala*. Based on the obtained results, the root extract has a better antibacterial activity against Gram positive bacteria except *L. monocytogenes* compared with seed extract while about of Gram negative bacteria the observed result is inverse. Thin Layer Chromatography can justify this difference, because the TLC results for seed and root extract showed that these extracts contain several bands with different density or even some bands exist in one extract that we have not been able to find in another one. So, the content of each of the constituents and nature of constituents for these two extracts can be the determinant factors in their antibacterial mechanisms.

Unlike other Gram positive bacteria, *L. monocytogenes* was more resistant to the seed extract than the root extract, this result may be caused by genetic factors which change the affinity of the active phytochemical of root extract to this bacterium or also it can be related to the nature and number of active phytochemicals in the seed and root extract of *P. harmala*. Tested *E. coli* was sensitive to the seed and root extract, this result is in agreement with the document of antibacterial activity of seed extract of *P. hamala* against *E. coli* serotype O~1~:K~1~ which has been reported previously (Arshad et al., 2008\[[@R5]\]). Antibacterial effect of active extracts against *K. pneumoniae* especially seed extract was remarkable compared with synthetic antibiotic (Figure 6[(Fig. 6)](#F6){ref-type="fig"}); this is an encapsulated bacterium that is considered as one of the most important causative agents of mortality in patients with bloodstream infections (Tenover, 2006\[[@R34]\]). So, these extract can be evaluated against other encapsulated clinical bacteria such as *Streptococcus pneumoniae*, which in this case forms a rather large capsule as its virulence factor and is involved in 60 % to 70 % of bacterial pneumonias which primarily affect immunocompromised patients (Talaro, 2009\[[@R33]\]). Figures 8[(Fig. 8)](#F8){ref-type="fig"} and 9[(Fig. 9)](#F9){ref-type="fig"} revealed that the seed and root extracts remained stable over a wide range of pH and temperature, so these extract can also be useful in some particular cases. For instance, pH stability is important in the treatment of brucellosis, one of the most important factors for the treatment of brucellosis is that the antibiotic should be able to act under acidic condition (pH 5) in phagolysosomes of macrophages because brucellae grow and replicate in this pH value (Akova et al., 1999\[[@R3]\]). Thus, considering antibacterial activity of the seed and root extracts of *P. harmala*against *Br. melitensis* and their pH resistance ability, this plant can be suggested for the treatment of brucellosis but in vivo efficacy remains to be confirmed. MIC and MBC values (Table 1[(Tab. 1)](#T1){ref-type="fig"}) for both seed and root extract against MRSA and seed extract against *E. coli* and *S. typhi* were the same, it is generally held that for bactericidal agents, the MIC and MBC are often near or equal values; so, it can be concluded that these extracts of *P. harmala* have a bactericidal effect on the mentioned bacteria (Reuben et al., 2008\[[@R28]\]). Nowadays, development of bactericidal agents against MRSA as the most important causative agent of nosocomial infections is valuable so antibacterial activity of seed and root extract of *P. harmala* must be tested against MRSA with more details. Our results indicate that crude extract of P*. harmala* seed and root exhibited synergistic effect in combination with novobiocin, colistin and carbenicillin against most important clinical pathogens. In general, combination therapy such as one resulted from synergism between antibiotic and plant extract can be used to as new choice for treatment of infections caused by MDR pathogens, to expand antibacterial spectrum, to prevent emergence of MDR pathogens and to minimize the possible toxic effects (Aiyegoro et al., 2009\[[@R1]\]\[[@R2]\]). Also, synergism between plant extract and synthetic antibiotics can develop standardization of herbal medicine for treatment and prevention of infectious diseases. Unlike the results that are shown in Figures 1[(Fig. 1)](#F1){ref-type="fig"} and 5[(Fig. 5)](#F5){ref-type="fig"} (without combination of extract with antibiotic), antibacterial activity of root extract associated with colistin against *E. coli* and *L. monocytogenes* was better than combination of the seed extract with this antibiotic (Table 3[(Tab. 3)](#T3){ref-type="fig"}). Colistin is an antibiotic that affects the cell membrane of bacteria. So, it is likely that the active phytochemicals, which exist in root extract, interfere with cell-wall petidoglycan synthesis in bacteria more than seed extract and finally resulted in increasing of the access of colistin to the cell membrane, the outcome of this event is increasing the synergistic effect. On the other hand, the active efflux pump in *E. coli* might be responsible for the high levels of intrinsic resistance of this bacterium to a wide range of antibiotics. So, may these extracts interfere with this pump and assumed as resistance modifying agents (McKeegan et al., 2002\[[@R21]\]; Coutinho et al., 2009\[[@R11]\]). So far, several alkaloids with pharmaceutical activity including harmine, harmane, harmalol, harmaline, vasicine, vasicinon and peganine have been obtained from the various parts of this plant (Fathiazada et al., 2006\[[@R17]\]; Goel et al., 2009\[[@R19]\]). It has been reported that harmane as a highly aromatic planar alkaloid exerts its antibacterial activity through interchalate with DNA (Cowan, 1999\[[@R12]\]), thus, this antibacterial mechanism must be considered for active extract of *P. harmala*.

Conclusion
==========

In conclusion, among evaluated parts of *P. harmala*, seed and root extract were possessed the most active phytochemicals and showed a broad spectrum and strong antibacterial activity against clinical bacterial pathogens. The reason of the difference between antibacterial effect of these two extracts against Gram positive and negative bacteria was justified using TLC, because of the difference in nature and content of active phytochemicals existing in these extract. The low values of MIC and MBC for these two active extracts against the most important of clinical bacterial pathogens especially MRSA was valuable. Also, pH and temperature stability of seed and root extract is important especially for treatment of brucellosis. On the other hand, these active extracts showed synergism in combination with novobiocin, carbenicillin and colisin against the most important clinical pathogens. More studies concerning about the molecular basis of this interaction must be performed in future.
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